Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer

Tiriac, Hervé, Belleau, Pascal, Engle, Dannielle D., Plenker, Dennis, Deschênes, Astrid, Somerville, Tim D. D., Froeling, Fieke E. M., Burkhart, Richard A. +62 more·2018·Cancer Discovery

DOI 10.1158/2159-8290.cd-18-0349

Cited by (1,001)

Items 501–600 of 1,001

Evolution of precision oncology‐guided treatment paradigms
Ramanuj DasGupta, Aixin Yap, Elena Yaqing Yong, Shumei Chia · 2022 · WIREs Mechanisms of Disease
Colorectal Cancer Modeling with Organoids: Discriminating between Oncogenic RAS and BRAF Variants
Jasmin B. Post, Jeanine M.L. Roodhart, Hugo J.G. Snippert · 2020 · Trends in cancer
Organoids as a new approach for improving pediatric cancer research
Silvia Lampis, Angela Galardi, Virginia Di Paolo, Angela Di Giannatale · 2024 · Frontiers in Oncology
The application of organoids in treatment decision-making for digestive system cancers: progress and challenges
Yufei Wang, Limin Zhang, Louis Zizhao Wang, Yang Cao, Lulu Huang, Gautam Sethi, Xiaoguang Chen, Lingzhi Wang, Boon Cher Goh · 2025 · Molecular Cancer
Blocking c-MET/ERBB1 Axis Prevents Brain Metastasis in ERBB2+ Breast Cancer
Shailendra Kumar Gautam, Ranjana Kumari Kanchan, Jawed Akhtar Siddiqui, Shailendra Kumar Maurya, Sanchita Rauth, Naveenkumar Perumal, Pranita Atri, Ramakanth Chirravuri Venkata, Kavita B. Mallya, Sameer Mirza et al. · 2020 · Cancers
Novel 3D µtissues Mimicking the Fibrotic Stroma in Pancreatic Cancer to Study Cellular Interactions and Stroma-Modulating Therapeutics
Kunal P. Pednekar, Marcel Alexander Heinrich, Joop van Baarlen, Jai Prakash · 2021 · Cancers
Progress and perspective of organoid technology in cancer-related translational medicine
Yu‐Sheng Lin, Li Jiang, Qiaojun He, Meng Yuan, Ji Cao · 2022 · Biomedicine & Pharmacotherapy
Tumor Organoids as a Research Tool: How to Exploit Them
Tijmen H. Booij, Chiara M. Cattaneo, Christian Hirt · 2022 · Cells
Amino acid transporter SLC38A5 is a tumor promoter and a novel therapeutic target for pancreatic cancer
Tyler Sniegowski, Devaraja Rajasekaran, Souad R. Sennoune, Sukumaran Sunitha, Fang Chen, Mohamed Fokar, Sudhir Kshirsagar, P. Hemachandra Reddy, Ksenija Korać, Mosharaf Mahmud Syed et al. · 2023 · Scientific Reports
A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma
Brandon M. Huffman, Hanrong Feng, Kalindi Parmar, Junning Wang, Kevin S. Kapner, Bose S. Kochupurakkal, David B. Martignetti, Golbahar Sadatrezaei, Thomas Adam Abrams, Leah H. Biller et al. · 2023 · Clinical Cancer Research
Combination immunohistochemistry for CK5/6, p63, GATA6, and HNF4a predicts clinical outcome in treatment-naïve pancreatic ductal adenocarcinoma
Takahiro Shibayama, Akimasa Hayashi, Toki Masao, Keiichiro Kitahama, Yu-Jui Ho, Kenichiro Kato, Takahiro Yamada, Sho Kawamoto, Komei Kambayashi, Kazushige Ochiai et al. · 2024 · Scientific Reports
RNA sequencing of long-term label-retaining colon cancer stem cells identifies novel regulators of quiescence
Joseph L. Regan, Dirk Schumacher, Stephanie Staudte, Andreas Steffen, Ralf Lesche, Joern Toedling, Thibaud Jourdan, Johannes Haybaeck, Dominik Mumberg, David Andrew Henderson et al. · 2021 · iScience
Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review)
Jessica Cao, Wing Hei Chan, Moses Chow · 2022 · International Journal of Oncology
Challenges and Opportunities Associated With Platelets in Pancreatic Cancer
Zhou Chen, Xiaodong Wei, Shi Dong, Fangfang Han, Ru He, Wence Zhou · 2022 · Frontiers in Oncology
Patient-derived organoids as a model for tumor research
Jia Wang, Xiaoying Feng, Zhichao Li, Yongsong Chen, Weiren Huang · 2022 · Progress in molecular biology and translational science
Patient-Derived Organoid Pharmacotyping Guides Precision Medicine for Pancreatic Cancer
Yuqing Zhang, Courtney W. Houchen, Min Li · 2022 · Clinical Cancer Research
Organoids as predictive platforms: advancing disease modeling, therapeutic innovation, and drug delivery systems
Ting Hsiang Huang, Wei Tao Huang, Qiong Bian · 2025 · Journal of Controlled Release
Multicellular Modelling of Difficult-to-Treat Gastrointestinal Cancers: Current Possibilities and Challenges
Sarah K. Hakuno, Ellis Michiels, Eleonore B Kuhlemaijer, Ilse Rooman, Lukas J.A.C. Hawinkels, Marije Slingerland · 2022 · International Journal of Molecular Sciences
Comprehensive multi-omics profiling identifies novel molecular subtypes of pancreatic ductal adenocarcinoma
Xing Wang, Jinshou Yang, Bo Ren, Gang Yang, Xiaohong Liu, Ruiling Xiao, Jie Ren, Feihan Zhou, Lei You, Yupei Zhao · 2023 · Genes & Diseases
Patient derived tumoroids of high grade neuroendocrine neoplasms for more personalized therapies
Simon April-Monn, Philipp Kirchner, Katharina M Detjen, Konstantin Bräutigam, Mafalda A. Trippel, Tobias J. Grob, Cyril Statzer, Renaud Maire, Attila Kollár, Aziz Chouchane et al. · 2024 · npj Precision Oncology
Organoid drug profiling identifies methotrexate as a therapy for SCCOHT, a rare pediatric cancer
Seok‐Young Kim, Tamar A. E. de Weert, Marijn A. Vermeulen, Femke C. A. S. Ringnalda, Lennart A. Kester, József Zsíros, Selma Eising, Jan J. Molenaar, Karin Sanders, Marc van de Wetering et al. · 2025 · Science Advances
The Anti-Tumor Effect of Nab-Paclitaxel Proven by Patient-Derived Organoids
Xing Xiao, Wei Chen, Zhe-Wei Wei, Weiwei Chu, Xiaofang Lu, Bo Li, Hong Chen, Sijun Meng, Tengfei Hao, Jitao Wei et al. · 2020 · OncoTargets and Therapy
Applications of Omics Technologies for Three-Dimensional In Vitro Disease Models
Vera M. Pieters, Ileana L. Co, Nila C. Wu, Alison P. McGuigan · 2021 · Tissue Engineering Part C Methods
Instructive Hydrogels for Primary Tumor Cell Culture: Current Status and Outlook
Yiyang Jia, Zhentong Wei, Songling Zhang, Bai Yang, Yunfeng Li · 2022 · Advanced Healthcare Materials
Application of tumoroids derived from advanced colorectal cancer patients to predict individual response to chemotherapy
Lei Yao, Xiao-Long Zao, Xiao-Fei Pan, Hao-Gang Zhang, Fu-Jing Wang, Peng-Fei Qiao · 2022 · Journal of Chemotherapy
Advances in the use of 3D colorectal cancer models for novel drug discovery
Ana Baião, Sofia Dias, Ana Francisca Soares, Catarina Leite Pereira, Carla Oliveíra, Bruno Filipe Carmelino Cardoso Sarmento · 2022 · Expert Opinion on Drug Discovery
Colon cancer organoids using monoclonal organoids established in four different lesions of one cancer patient reveal tumor heterogeneity and different real-time responsiveness to anti-cancer drugs
Myoung-Hyun Song, Ji Won Park, Min Jung Kim, Young‐Kyoung Shin, Soon‐Chan Kim, Seung‐Yong Jeong, Ja‐Lok Ku · 2022 · Biomedicine & Pharmacotherapy
Genetic Ancestry Inference from Cancer-Derived Molecular Data across Genomic and Transcriptomic Platforms
Pascal Belleau, Astrid Deschênes, Nyasha Chambwe, David Arthur Tuveson, Alexander Krasnitz · 2022 · Cancer Research
TissueGrinder, a novel technology for rapid generation of patient-derived single cell suspensions from solid tumors by mechanical tissue dissociation
Stefan Scheuermann, Jonas M. Lehmann, Ramkumar Ramani Mohan, Christoph Reißfelder, Felix Rückert, Jens Langejürgen, Prama Pallavi · 2022 · Frontiers in Medicine
Building towards Precision Oncology for Pancreatic Cancer: Real-World Challenges and Opportunities
Yifan Wang, Anna Lakoma, George Zogopoulos · 2020 · Genes
Epigenetic Landscape of DNA Methylation in Pancreatic Ductal Adenocarcinoma
Peinan Liu, Juliette Jacques, Chang‐Il Hwang · 2024 · Epigenomes
Experimental models of pancreas cancer: what has been the impact for precision medicine?
Vasiliki Pantazopoulou, Casie S. Kubota, Satoshi Ogawa, Kevin Christian Montecillo Gulay, Xiaoxue Lin, Hyemin Song, Jonathan Weitz, Hervé Tiriac, Andrew M. Lowy, Dannielle D. Engle · 2025 · Journal of Clinical Investigation
USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable therapeutic vulnerabilities
Naiara Perurena, Rebecca Lock, Rachel A. Davis, Srivatsan Raghavan, Natalie F. Pilla, Raymond W.S. Ng, Patrick Loi, Caroline J. Guild, Abigail L. Miller, Ewa Sicińska et al. · 2023 · Cell Reports Medicine
Advanced in vitro models for renal cell carcinoma therapy design
Valentin Mieville, Arjan W. Griffioen, Daniel A. Benamran, Patrycja M. Nowak-Sliwinska · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer
Simon Ezban Grützmeier, Bojan Kovacevic, Peter Vilmann, Charlotte Vestrup Rift, Linea Cecilie Melchior, Morten Orebo Holmström, Lene Brink, Hazem Hassan, John Gásdal Karstensen, Hanne Grossjohann et al. · 2023 · Cancers
Personalized treatment in localized pancreatic cancer
John P. Neoptolemos, Kai Hu, Peter J. Bailey, Christoph Springfeld, Baobao Cai, Yi Miao, Christoph W. Michalski, Carlos Torres Carvalho, Thilo Hackert, Markus Wolfgang Büchler · 2023 · European surgery. Supplement/European surgery
Advancements in Preclinical Models of Pancreatic Cancer
Philip Salu, Katie M. Reindl · 2024 · Pancreas
Establishing mesothelioma patient-derived organoid models from malignant pleural effusions
Ashleigh Jean Hocking, Lauren A. Mortimer, Alexandra L. Farrall, Prudence Anne Russell, Sonja Klebe · 2024 · Lung Cancer
Interpretation of the past, present, and future of organoid technology: an updated bibliometric analysis from 2009 to 2024
Baozhen Qu, Qiang Mu, Huanhuan Bi, Yuxian Chen, Qitang Wang, Xuezhen Ma, Linlin Lu · 2024 · Frontiers in Cell and Developmental Biology
Precision preclinical modeling to advance cancer treatment
David H. Gutmann, Jesse S. Boehm, Elinor K. Karlsson, Eric Padron, Mukund Seshadri, DEEANN E. WALLIS, Joshua C. Snyder · 2024 · JNCI Journal of the National Cancer Institute
Tumor organoids improve mutation detection of pancreatic ductal adenocarcinoma
Elham Aïda Farshadi, Wenya Wang, Farzana Mohammad, Elise van der Oost, Michail Doukas, Casper H.J. van Eijck, Harmen J.G. van de Werken, Peter D. Katsikis · 2024 · Scientific Reports
Development of patient-derived lymphomoids with preserved tumor architecture for lymphoma therapy screening
Albert Santamaria‐Martínez, Justine Epiney, Divyanshu Srivastava, Daniele Tavernari, Marco Varrone, Dina Milowich, Igor Letovanec, Thorsten Krueger, Rafael Durán, Giovanni Ciriello et al. · 2024 · Nature Communications
A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer
Juliana Calheiros, Rita Silva, Filipa Barbosa, João Morais, Sara Reis Moura, Sofia Almeida, Elena Fiorini, Silva Mulhovo, Tatiana Quinta Aguiar, Tao Wang et al. · 2025 · Journal of Experimental & Clinical Cancer Research
Application and research progress of organoids in cholangiocarcinoma and gallbladder carcinoma.
Yun-peng Huang, Kai Liu, Yongxiang Wang, Yang Yang, Li Xiong, Zijian Zhang, Yu Wen · 2021 · PubMed Central
Identification of laminin γ2 as a prognostic and predictive biomarker for determining response to gemcitabine-based therapy in pancreatic ductal adenocarcinoma
Yasuyuki Okada, Satoshi Nishiwada, Kensuke Yamamura, Masayuki Sho, Hideo Baba, Tetsuji Takayama, Ajay Goel · 2021 · European Journal of Cancer
Future Match Making: When Pediatric Oncology Meets Organoid Technology
Virginie Barbet, Laura Broutier · 2021 · Frontiers in Cell and Developmental Biology
Establishment of organoids using residual samples from saline flushes during endoscopic ultrasound-guided fine-needle aspiration in patients with pancreatic cancer
Kenji Ikezawa, Tomoya Ekawa, Shinichiro Hasegawa, Yugo Kai, Ryoji Takada, Takuo Yamai, Nobuyasu Fukutake, Hisataka Ogawa, Takashi Akazawa, Yu Mizote et al. · 2022 · Endoscopy International Open
Optimization of endometrial cancer organoids establishment by cancer-associated fibroblasts
Yu-Liang Wu, Jiaqing Li, Zubaidan Sulaiman, Qi Liu, Chunyan Wang, Shupeng Liu, Zhengliang Gao, Zhongping Cheng · 2022 · Neoplasma
An Organotypic Microcosm for the Pancreatic Tumor Microenvironment
Miranda Lin, Mei Gao, Prakash Krishnan Pandalai, Michael J. Cavnar, Joseph Kim · 2020 · Cancers
Does the Microenvironment Hold the Hidden Key for Functional Precision Medicine in Pancreatic Cancer?
John Kokkinos, Anya Jensen, George Sharbeen, Joshua A. McCarroll, David Goldstein, Koroush Shahsavar Haghighi, Phoebe A. Phillips · 2021 · Cancers
CRISPR–Drug Combinatorial Screening Identifies Effective Combination Treatments for MTAP -Deleted Cancer
Nikola Knoll, Sarah Masser, Blanka Bordas, Richard Y. Ebright, Guangyan Li, Devishi Kesar, Eliana Destefanis, Nicholas Kania, Diego J. Rodriguez, Jayu Jen et al. · 2025 · Cancer Research
Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancer
Kenneth H. Yu, Jennifer Park, Avni Mittal, Ghassan K. Abou‐Alfa, Imane El Dika, Andrew S. Epstein, David H. Ilson, David Paul Kelsen, Geoffrey Yuyat Ku, Jia Li et al. · 2022 · Cancer
Challenges in genomic analysis of model systems and primary tumors of pancreatic ductal adenocarcinoma
Sangyeop Hyun, Daechan Park · 2022 · Computational and Structural Biotechnology Journal
Emerging target discovery and drug repurposing opportunities in chordoma
Daniel M. Freed, Josh Sommer, Nindo B. Punturi · 2022 · Frontiers in Oncology
PRKRA promotes pancreatic cancer progression by upregulating MMP1 transcription via the NF-κB pathway
Jiangdong Qiu, Mengyu Feng, Gang Yang, Dan Su, Fangyu Zhao, Yueze Liu, Jinxin Tao, Wenhao Luo, Taiping Zhang · 2023 · Heliyon
EUS-guided biopsies versus surgical specimens for establishing patient-derived pancreatic cancer organoids: a systematic review and meta-analysis
Simon Ezban Grützmeier, Hafsa Mahad Mahamud Sodal, Bojan Kovacevic, Peter Vilmann, John Gásdal Karstensen, Pia Helene Klausen · 2024 · Gastrointestinal Endoscopy
A Targetable Secreted Neural Protein Drives Pancreatic Cancer Metastatic Colonization and HIF1α Nuclear Retention
Norihiro Yamaguchi, Y. Gloria Wu, Ethan Ravetch, M Takahashi, Abdul G. Khan, Akimasa Hayashi, Wenbin Mei, Dennis J. Hsu, Shigeaki Umeda, Elisa de Stanchina et al. · 2024 · Cancer Discovery
Gastrointestinal Cancer Patient Derived Organoids at the Frontier of Personalized Medicine and Drug Screening
Zhenjie Yang, Jun Qing Yu, Chi Chun Wong · 2024 · Cells
Development of transcriptomic tools for predicting the response to individual drug of the mFOLFIRINOX regimen in patients with metastatic pancreatic cancer
Nicolas Alejandro Fraunhoffer, Carlos Teyssedou, Patrick Pessaux, Martin Bigonnet, Nelson Dusetti, Juan Iovanna · 2024 · Frontiers in Oncology
Patient-derived model systems and the development of next-generation anticancer therapeutics
Nikolaus Krall, Giulio Superti‐Furga, Gregory Ian Vladimer · 2020 · Current Opinion in Chemical Biology
Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study
Luca Nicosia, Filippo Alongi, Silvia Andreani, Ruggero Ruggieri, Borislav Chavdarov Rusev, Beatrice Mantoan, Rita Teresa Lawlor, Antonio Pea, Aldo Scarpa, Linda Agolli et al. · 2020 · Biomedicines
Molecular, metabolic, and histological subtypes of pancreatic ductal adenocarcinoma and its tumor microenvironment: Insights into tumor heterogeneity and clinical implications
Yuuki Ohara, Huaitian Liu, Paloma Moreno, Seiya Suzuki, S. Perwez Hussain · 2025 · Pharmacology & Therapeutics
Patient-derived organoids predict responses to chemotherapy and PARP inhibitors in advanced ovarian cancer
Haixia Wang, Ling Wang, Xueping Zhu, Misi He, Lin Zhong, Yuyu Lv, Qiaoling Li, Qinyue Jiang, Cong Zhang, Xinghe Liu et al. · 2026 · Journal of Translational Medicine
Prognostic Impact of DHRS9 Overexpression in Pancreatic Cancer
Huang-bao Li, Jun Zhou, Fengqing Zhao, Jiayin Yu, Longsheng Xu · 2020 · Cancer Management and Research
Tailoring Adjuvant Chemotherapy to Biologic Response Following Neoadjuvant Chemotherapy Impacts Overall Survival in Pancreatic Cancer
Elie M. Ghabi, Sami Shoucair, Ding Ding, Ammar A. Javed, Elizabeth D. Thompson, Lei Zheng, John L. Cameron, Christopher L. Wolfgang, Christopher R. Shubert, Kelly J. Lafaro et al. · 2022 · Journal of Gastrointestinal Surgery
Establishment of gastric cancer organoid and its application in individualized therapy
Xin Miao, Caiming Wang, Changpeng Chai, Huan Tang, Jinjing Hu, Zhenjie Zhao, Wei Luo, Hui Zhang, Kexiang Zhu, Wence Zhou et al. · 2022 · Oncology Letters
New Therapeutic Perspectives in Prostate Cancer: Patient-Derived Organoids and Patient-Derived Xenograft Models in Precision Medicine
Vittoria Rago, Anna Perri, Silvia Di Agostino · 2023 · Biomedicines
Exploring tumor organoids for cancer treatment
Hairong Jin, Qian Yang, Jing Yang, Fangyan Wang, Jiayin Feng, Lanjie Lei, Minghai Dai · 2024 · APL Materials
Identification and validation of a T cell receptor targeting KRAS G12V in HLA-A*11:01 pancreatic cancer patients
Xiongfei Xu, Shiwei Guo, Haihui Gu, Zhanshan Cha, Xiaohan Shi, Xiaoyi Yin, Huan Wang, Suizhi Gao, Bo Li, Lingyu Zhu et al. · 2025 · JCI Insight
Advances and Challenges in Human 3D Solid Tumor Models
Naveen R. Natesh, Shyni Varghese · 2025 · Advanced Functional Materials
Immunomodulatory Natural Products in Cancer Organoid-Immune Co-Cultures: Bridging the Research Gap for Precision Immunotherapy
Chang‐Eui Hong, Su‐Yun Lyu · 2025 · International Journal of Molecular Sciences
Newly established gastrointestinal cancer cell lines retain the genomic and immunophenotypic landscape of their parental cancers
Daniela D. Hirsch, Steffen Seyfried, Tobias Staib, David Fiedler, Christian Georg Sauer, Thomas Ried, Stephanie H. Witt, Felix Rueckert, Timo Gaiser · 2020 · Scientific Reports
Modeling colorectal cancers using multidimensional organoids
Ibrahim M. Sayed, Amer Ali Abd El‐Hafeez, Priti Prasanna Maity, Soumita Das, Pradipta Ghosh · 2021 · Advances in cancer research
Challenges in precision medicine in pancreatic cancer: A focus in cancer stem cells and microbiota
Catalina M. Perelló-Reus, Teresa Rubio‐Tomás, Eugenia Cisneros Barroso, Lesly Ibargüen-González, Juan José Segura‐Sampedro, Rafael Morales-Soriano, Carles Barceló · 2022 · Frontiers in Oncology
Pancreatic cancer derived 3D organoids as a clinical tool to evaluate the treatment response
Hem Dutt Shukla, Tijana Đukić, Sanjit Kumar Roy, Binny Bhandary, Andrew Gerry, Yannick P. Poirier, Narottam Lamichhane, Jason K. Molitoris, France Carrier, Aditi Banerjee et al. · 2023 · Frontiers in Oncology
Functional Precision Oncology: The Next Frontier to Improve Glioblastoma Outcome?
Dena Panovska, Frederik De Smet · 2022 · International Journal of Molecular Sciences
The need to develop a framework for human-relevant research in India: Towards better disease models and drug discovery
Surat Parvatam, Sham Bharadwaj, Vegesna Radha, Madhusudhana Rao · 2020 · Journal of Biosciences
Airway Organoid Models as Pivotal Tools for Unraveling Molecular Mechanisms and Therapeutic Targets in Respiratory Diseases: A Literature Review
Shuping Jiang, Bing-Qi Lin, Xin Zhou, Minhua Li, Zhencheng Feng, Yue-Ying Qin, Shiqi Lin, Ziqing Zhou, Yang Peng, Lian Li · 2025 · Therapeutics and Clinical Risk Management
Lung organoids: a new frontier in neonatology and paediatric respiratory medicine
Lorenzo Zanetto, Luca Bonadies, Raquel Moll‐Diaz, Jeffrey Matthijn Beekman, Maurizio Muraca, Michela Pozzobon, Eugenio Baraldi · 2025 · European Respiratory Review
Organoids derived from metastatic cancers: Present and future
Xuejing Zheng, Xinxin Zhang, Shengji Yu · 2024 · Heliyon
Pancreatic cancer organoid-screening captures personalized sensitivity and chemoresistance suppression upon cytochrome P450 3A5-targeted inhibition
Meritxell B. Cutrona, Jing Wu, Ka Yang, Junmin Peng, Taosheng Chen · 2024 · iScience
Exploring epigenetic dynamics unveils a super-enhancer-mediated NDRG1-β-catenin axis in modulating gemcitabine resistance in pancreatic cancer
Dianhui Wei, Lili Yuan, Xiaoli Xu, Chengsi Wu, Yi‐Wen Huang, Jilong Zhang, Jilong Zhang, Tiantian Jing, Yizhen Liu, Boshi Wang · 2024 · Cancer Letters
Modeling Clinical Radioiodine Uptake By Using Organoids Derived From Differentiated Thyroid Cancer
Xinyue Zhang, Jiaye Liu, Yinyun Ni, Ying Yang, Tian Tian, Xiaofeng Zheng, Zhihui Li, Rui Huang · 2024 · Endocrinology
Patient-derived organoids from pancreatic cancer after pancreatectomy: Feasibility and organoid take rate in treatment-naïve periampullary tumors
Marcus T. T. Roalsø, Marina Alexeeva, Celine Oanæs, Martin M. Watson, Dordi Lea, Claudia Zaharia, Hanne Røland Hagland, Kjetil Søreide · 2024 · Pancreatology
Clinical efficacy and chemoresistance analysis of precision neoadjuvant chemotherapy for borderline resectable pancreatic cancer: a prospective, single-arm pilot study
Yonggang He, Yinan Zhu, Weiwei Wang, Yuqing Yi, Zheng Wang, Chongyu Zhao, Jing Li, Xiaobing Huang, Lu Zheng · 2025 · International Journal of Surgery
CD44 identified as a diagnostic biomarker for highly malignant CA19-9 negative pancreatic cancer
Jiatong Tang, Xiaoyang Li, Neng Tang, Xiawen Lin, Yixiang Du, Shuo Zhang, Qi Li, Yifan Zhang, Yixuan Zhang, Hexing Hang et al. · 2025 · Cancer Letters
Applications and challenges of patient-derived organoids in hepatobiliary and pancreatic cancers
Jia-Wei Hu, Yanzhi Pan, Xiaoxiao Zhang, Jiangtao Li, Yun Jin · 2025 · World Journal of Gastroenterology
Patient-Derived In Vitro and In Vivo Models of Cancer
Sally E. Claridge, Julie‐Ann Cavallo, Benjamin David Hopkins · 2022 · Advances in experimental medicine and biology
Complex in vitro 3D models of digestive system tumors to advance precision medicine and drug testing: Progress, challenges, and trends
Shenglei Song, Bo Li, Mariana R. Carvalho, Huijun Wang, Deli Mao, Jitao Wei, Wei Chen, Zhi-Hui Weng, Yangchao Chen, Chu‐Xia Deng et al. · 2022 · Pharmacology & Therapeutics
Utilizing Patient-Derived Organoids in the Management of Colorectal Cancer with Peritoneal Metastases: A Review of Current Literature
Richard A. Erali, Steven Donald Forsythe, Daniel J. Gironda, Cecilia R. Schaaf, Nadeem Wajih, Shay Söker, Konstantinos Ioannis Votanopoulos · 2022 · Journal of Gastrointestinal Cancer
How organoids can improve personalized treatment in patients with gastro-esophageal tumors
Manuel Cabeza-Segura, Blanca García-Micó, Marcella La Noce, Giovanni Francesco Nicoletti, Valeria Conti, Amelia Filippelli, Tania Fleitas, Andrès M.R. Cervantes, Josefa Castillo, Federica Papaccio · 2023 · Current Opinion in Pharmacology
Two rare cancers of the exocrine pancreas: to treat or not to treat like ductal adenocarcinoma?
Nebojša Skorupan, Shadin Ghabra, Jose Alberto Maldonado, Yang Zhang, Christine Alewine · 2023 · Journal of Cancer Metastasis and Treatment
NPEPPS Is a Druggable Driver of Platinum Resistance
Robert T. Jones, Mathijs Scholtes, Andrew E. Goodspeed, Maryam Akbarzadeh, Saswat Mohapatra, Lily Elizabeth Feldman, Hedvig Vékony, Annie Jean, Charlene B. Tilton, Michael V. Orman et al. · 2024 · Cancer Research
Molecular biology in pancreatic ductal adenocarcinoma: implications for future diagnostics and therapy
Kjetil Søreide, Florian Primavesi, Knut Jørgen Labori, Martin M. Watson, Stefan Stättner · 2019 · European surgery. Supplement/European surgery
Up-to-Date Tailored Systemic Treatment in Pancreatic Ductal Adenocarcinoma
Caroline Fong, Emma Burke, David Cunningham, Naureen Starling · 2019 · Gastroenterology Research and Practice
New era for pancreatic endoscopic ultrasound: From imaging to molecular pathology of pancreatic cancer
Lívia Archibugi, Sabrina Gloria Giulia Testoni, Miriam Redegalli, Maria Chiara Petrone, Michele Reni, Massimo Falconi, Claudio Doglioni, Gabriele Capurso, Paolo Giorgio Arcidiacono · 2019 · World Journal of Gastrointestinal Oncology
Upfront molecular profiling of pancreatic cancer patients – An idea whose time has come
Manoop S. Bhutani, Irina Mihaela Cazacu, Sinchita Roy‐Chowdhuri, Anirban Maitra, Michael Jon Pishvaian · 2020 · Pancreatology
Novel patient-derived 3D culture models to guide clinical decision-making in prostate cancer
Annelies Van Hemelryk, Wytske M. van Weerden · 2020 · Current Opinion in Endocrine and Metabolic Research
Modeling human pancreatic ductal adenocarcinoma for translational research: current options, challenges, and prospective directions
Reecha Suri, Jacquelyn W. Zimmerman, Richard Andrew Burkhart · 2020 · Annals of Pancreatic Cancer
Nucleolin Targeting by N6L Inhibits Wnt/β-Catenin Pathway Activation in Pancreatic Ductal Adenocarcinoma
Fabio Raineri, Sandrine Bourgoin‐Voillard, Mélissande Cossutta, Damien Habert, Matteo Ponzo, Claire Houppe, Benoît Vallée, Michele Boniotto, Mounira Chalabi‐Dchar, Philippe Bouvet et al. · 2021 · Cancers